Effectiveness, safety, and acceptability of postplacental insertion of GyneFix postpartum intrauterine device among women undergoing cesarean section: A multicenter prospective cohort study in China
Contraception · 2023-06 · 122 · 109999
DOI: 10.1016/j.contraception.2023.109999 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Contraception, 2023-06. Verfasst von Yan Che und 15 weiteren Autor:innen. Beteiligte Einrichtung: NHC Key Lab of Reproduction Regulation, Shanghai Institute for Biomedical and Pharmaceutical Technologies, Shanghai, China; Departiment of Family Pla…. Hauptthemen laut MEDLINE: Intrauterine Devices, Intrauterine Devices, Copper. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Chinese Academy of Sciences.
Abstract (Originalsprache)
OBJECTIVES: To assess the effectiveness, safety, and acceptability of postplacental insertion of GyneFix postpartum intrauterine device (PPIUD) in women undergoing cesarean section (C-section). STUDY DESIGN: We conducted a prospective cohort study at 14 hospitals in four eastern coastal provinces of China between September 2017 and November 2020. A total of 470 women who underwent C-section and consented to the postplacental insertion of GyneFix PPIUD were enrolled, and 400 completed the 12-month follow-up. Participants were interviewed in the wards after delivery and followed up at 42 days, and months 3, 6, and 12 after delivery. We used Pearl Index (PI) to measure the rate of contraceptive failure, life-table method to measure the rate of PPIUD discontinuation, including IUD expulsion, and Cox regression model to explore the risk factors associated with discontinuation of the device. RESULTS: Nine pregnancies were detected during the first year after GyneFix PPIUD insertion: seven were due to device expulsion and two occurred with PPIUD in situ. The PIs for overall 1-year pregnancy rate and pregnancies with IUD in situ were 2.3 (95% CI: 1.1-4.4) and 0.5 (95% CI: 0.1-1.9), respectively. The 6- and 12-month cumulative expulsion rates for PPIUD expulsion were 6.3% and 7.6%, respectively. The overall 1-year continuation rate was 86.6% (95% CI: 83.3-89.8). We did not identify any patient with insertion failure, uterine perforation, pelvic infection, or excess bleeding due to GyneFix PPIUD insertion. Women's age, education, occupation, previous history of C-section, parity, and breastfeeding were not associated with removal of GyneFix PPIUD in the first year of use. CONCLUSIONS: Postplacental insertion of GyneFix PPIUD is effective, safe, and acceptable for women undergoing C-section. Expulsion is the most common reason for GyneFix PPIUD discontinuation and pregnancy. The expulsion rate for GyneFix PPIUD is lower than that for framed IUDs, but more evidence is needed for a firm verdict.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- NHC Key Lab of Reproduction Regulation, Shanghai Institute for Biomedical and Pharmaceutical Technologies, Shanghai, China; Departiment of Family Planning, Weifang People's Hospital, Shandong, China. Electronic address:…
- Department of Obstetrics, The Second People's Hospital of Huadu District, Guangzhou, China.
- Department of Obstetrics, Wenzhou People's Hospital, Wenzhou, China.
- Department of Obstetrics, Shenzhen Luohu Maternal and Child Health Hospital, Shenzhen, China.
- Department of Obstetrics, Jiangmen Maternity and Child Health Care Hospital, Jiangmen, China.
- Department of Obstetrics, Jun'an Hospital, Shunde Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
Förderung
- University of Chinese Academy of Sciences
Zitieren
APA
Che, Y., Hou, G. F., Zhang, H. P., Yang, H., Lin, S. J., Gan, T., Yang, W. H., Shi, C. H., Ren, W. J., Xu, Y. Q., Yin, B. M., Chen, T. T., Gan, Y. J., Zhang, Y., Zhang, Y., & Cheng, L. N. (2023). Effectiveness, safety, and acceptability of postplacental insertion of GyneFix postpartum intrauterine device among women undergoing cesarean section: A multicenter prospective cohort study in China. Contraception, 122, 109999. https://doi.org/10.1016/j.contraception.2023.109999
Vancouver
Che Y, Hou GF, Zhang HP, Yang H, Lin SJ, Gan T, et al. Effectiveness, safety, and acceptability of postplacental insertion of GyneFix postpartum intrauterine device among women undergoing cesarean section: A multicenter prospective cohort study in China. Contraception. 2023;122:109999. doi:10.1016/j.contraception.2023.109999
BibTeX
@article{Che2023,
author = {Che, Yan and Hou, Gui-Fang and Zhang, Hong-Ping and Yang, Heng and Lin, Shu-Juan and Gan, Tao and Yang, Wei-Hua and Shi, Chun-Hui and Ren, Wei-Juan and Xu, Ying-Qin and Yin, Bao-Ming and Chen, Ting-Ting and Gan, Yu-Jie and Zhang, Yuan and Zhang, Yan and Cheng, Li-Nan},
title = {Effectiveness, safety, and acceptability of postplacental insertion of GyneFix postpartum intrauterine device among women undergoing cesarean section: A multicenter prospective cohort study in China},
journal = {Contraception},
year = {2023},
volume = {122},
pages = {109999},
doi = {10.1016/j.contraception.2023.109999}
}
EUVIMED